Rein Therapeutics RNTX
NASDAQ RNTX
$0.60 -0.02 (-3.92%)
As of: Oct 22, 2026 · 12:03 PM EDT

Rein Therapeutics (RNTX) Total Debt (2018 - 2026)

Updated

Rein Therapeutics (RNTX) recorded Total Debt of $4.92 million in Q1 2026.

Analysis

Rein Therapeutics (RNTX) Total Debt (2018 - 2026) Analysis & Trends

At the end of FY2018, Rein Therapeutics reported Total Debt of $5.34 million.

  • The Q1 2026 figure is the highest quarterly Total Debt since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn 49.04 Bn
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn 70.82 Bn
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn 32.35 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 63.19 Bn
10 Rein Therapeutics 40.26 Mn -3.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.92 Mn
Dec 31, 2018 5.34 Mn
Sep 30, 2018 5.00 Mn
Jun 30, 2018 3.35 Mn
API Access

Rein Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RNTX&period=max&api_key=YOUR_API_KEY